Pharma Journalist -

The US FDA accepted Bristol-Myers Squibb supplemental BLA to extend the use of Opdivo (nivolumab) to patients with hepatocellular carcinoma (HCC) after prior sorafenib therapy. The FDA…
Read More...

Constellation Pharmaceuticals has appointed Jigar Raythatha as president and CEO. He will lead the company focused on harnessing its deep scientific expertise in cancer epigenetics, to…
Read More...

Optum announced that they will collaborate with Merck to explore value-based and pay-for-performance models, known as Outcomes-Based Risk Sharing Agreements (OBRSAs), and their…
Read More...

PharmaMar has signed agreement with Eczacibasi Group to commercialize the marine-derived anticancer drug Aplidin (plitidepsin) in Turkey. Aplidin is PharmaMar´s second most advanced…
Read More...

The U.S. Patent and Trademark Office has issued a Notice of Allowance in favour of Ammonett Pharma for Patent Application No: 15/271,542, entitled “DETECTING AND TREATING GROWTH HORMONE…
Read More...

Akebia Therapeutics has appointed Rita Jain, M.D. as Senior VP and CMO. She will be responsible for leading the clinical development of the Company's HIF pipeline, including the global…
Read More...

TrialScope has announced the launch its second Clinical Trial Disclosure Maturity Survey for clinical trial sponsors to perform self-assessments of their disclosure practices. The…
Read More...

miRagen Therapeutics announced that  MRG-106 has received orphan medicinal product designation from European Commission (EC) for the treatment of cutaneous T-cell lymphoma (CTCL). CTCL…
Read More...

Sun Pharmaceutical Industries announced that USFDA has accepted BLA for tildrakizumab submitted by Merck & Co., USA. The FDA filing acceptance follows acceptance of the regulatory…
Read More...

KBI Biopharma announced that they have planned to invest $30M for expanding its biopharmaceutical manufacturing capacity at both its Durham, NC, and Boulder, CO, facilities. KBI is…
Read More...